The US Department of Defense ordered another 300 million doses of COVID-19 vaccine developed by Pfizer and BioNTech with delivery in 2022. Thus, the volume of the Department's order for 2022 reached 1 billion doses. The total value of all contracts amounted to $6.9 billion. The DOD will supply the vaccine to low- and middle-income countries.